Ripretinib, sold under the brand name Qinlock, is a medication for the treatment of adults with advanced gastrointestinal stromal tumor (GIST). Reference standards of Ripretinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Ripretinib
Catalogue No.:PA 18 1440000
CAS :
Molecular Formula : C24H21BrFN5O2
Molecular Weight : 510.37
3-(5-Amino-2-bromo-4-fluorophenyl)-1-ethyl-7-(methylamino)-1,6-naphthyridin-2(1H)-one
Catalogue No.:PA 18 1441000
Molecular Formula : C17H16BrFN4O
Molecular Weight : 391.24
1-(4-Bromo-5-(7-(dimethylamino)-1-ethyl-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea
Catalogue No.:PA 18 1441001
Molecular Formula : C25H23BrFN5O2
Molecular Weight : 524.39
1-(3-(2-Bromo-4-fluoro-5-(3-phenylureido)phenyl)-1-ethyl-2-oxo-1,2-dihydro-1,6-naphthyridin-7-yl)-1-methyl-3-phenylurea
Catalogue No.:PA 18 1441002
Molecular Formula : C31H26BrFN6O3
Molecular Weight : 629.49
N-Nitroso Ripretinib
Catalogue No.:PA 18 1441003
Molecular Formula : C24H20BrFN6O3
Molecular Weight : 539.37
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
